查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813584

全球单株抗体市场分析与预测（至 2034 年）：类型、产品、应用、技术、最终用户、流程、服务、形式、部署和格式

Monoclonal Antibody Market Analysis and Forecast to 2034: Type, Product, Application, Technology, End User, Process, Services, Form, Deployment, Mode
出版日期: | 出版商: Global Insight Services | 英文 376 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球单株抗体市场预计将从 2024 年的 2,511 亿美元扩大到 2034 年的 8,374 亿美元，复合年增长率约为 12.8%。单株抗体市场涉及针对特定抗原的抗体的开发和商业化。这些生技药品对于治疗各种疾病至关重要，包括癌症、自体免疫疾病和感染疾病。该市场受到生物技术进步、慢性病发病率上升以及对标靶治疗日益增长的需求的驱动。生产技术和监管核准的创新进一步推动了市场成长，为相关人员提供了丰厚的机会。

在生物技术进步和治疗应用日益增多的推动下，单株抗体市场正在强劲扩张。由于癌症发病率上升以及单株抗体在靶向特定癌细胞方面的有效性，肿瘤学领域是最强大的细分市场。自体免疫疾病领域受益于有效调节免疫反应的新型抗体的开发。在治疗应用领域，感染疾病领域已成为一个前景光明的领域，单株抗体正应用于病毒感染疾病的治疗。心血管疾病领域也显示出潜力，针对心臟病特定途径的研究取得了进展。对个人化医疗的需求进一步加速了市场的成长轨迹，因为单株抗体可以实现客製化的治疗方法。对研发和策略伙伴关係的投资对于推动创新和扩大单株抗体在不同病理学中的治疗范围至关重要。

市场区隔
类型 小鼠、嵌合体、人源化、人类、双特异性、共轭、多克隆抗体、单克隆
产品 治疗性抗体、诊断性抗体、研究性抗体、客製化抗体
目的 肿瘤学、自体免疫疾病、感染疾病、神经病学、心血管疾病、发炎性疾病、移植、血液学
科技 融合瘤技术、噬菌体展示、基因转殖小鼠、细菌展示、酵母展示、单B细胞扩增法
最终用户 医院、研究机构、生物製药公司、诊断实验室、合约研究组织
过程 体内、体外、电脑模拟
服务 抗体生产、抗体工程、抗体标记、抗体纯化、抗体片段化
形式 液体，冻干
部署 内部、外包
格式 治疗和预防

市场概述

单株抗体市场的特点是市场份额分布动态，主要企业透过策略定价和创新产品发布不断争夺主导地位。竞争格局的特点是，在技术进步和各治疗领域需求不断增长的推动下，产品平臺强劲成长。定价策略仍然是一个关键方面，并受製造复杂性和法律规范的影响，而这反过来又决定了市场准入和采用率。生物相似药的快速推出反映了向具有成本效益的替代品和更广泛的市场渗透的趋势。单株抗体市场的竞争非常激烈，主要企业透过研发投资和策略联盟相互基准化分析。监管影响起着关键作用，特别是在北美和欧洲，因为严格的核准程序决定了市场进入和扩张。专利到期进一步影响市场，这推动了向生物相似药的转变并加剧了价格战。对市场动态的分析揭示了个人化医疗的发展轨迹，而单株抗体则处于最前线。由于生物技术的进步和慢性疾病的增加，市场有望成长，为相关人员提供有利可图的机会。

主要趋势和驱动因素

在生物技术和基因工程进步的推动下，单株抗体市场正经历强劲成长。癌症和自体免疫疾病等慢性疾病的日益流行是标靶治疗需求的主要驱动力。单株抗体提供精准的治疗选择，最大限度地减少副作用，并改善患者的治疗效果。製药公司增加研发投入进一步推动了市场的发展。抗体药物复合体和双特异性抗体的创新正在提高治疗效果并创造有利可图的机会。新型单株抗体的监管核准正在加速，推动了市场扩张。此外，COVID-19 大流行凸显了单株抗体在感染疾病管理中的重要性，刺激了其在新的治疗领域的应用。个人化医疗的趋势也在塑造市场，因为单株抗体可以根据个别患者的需求进行客製化。凭藉强大的产品平臺和策略合作伙伴关係，单株抗体市场有望持续成长。

限制与挑战：

目前，单株抗体市场面临许多重大限制和挑战。其中最主要的限制因素之一是高昂的生产和开发成本。这种经济负担限制了这些疗法的可近性和可负担性，尤其是在新兴市场。监管的复杂性进一步加剧了这一局面，严格的指导方针和冗长的核准流程延缓了新产品的上市时间。供应链中断也构成了重大挑战。对专业设施和材料的依赖使市场容易受到地缘政治紧张局势和流行病的影响，从而导致库存短缺和成本上升。此外，生物相似药的兴起带来了竞争压力，迫使企业在控製成本的同时不断创新。最后，市场面临针对复杂疾病的科学挑战。儘管技术不断进步，但开发针对特定疾病的抗体仍然具有挑战性，需要持续的研究和大量的投资。这些因素共同阻碍了市场扩张的潜力。

主要企业

BioXcel Therapeutics、Aptevo Therapeutics、Argenx、MacroGenics、ImmunoGen、Xencor、Cellectis、MorphoSys、Alligator Bioscience、Genmab、AbCellera、Kymab、Tiziana Life Sciences、Harpoon Therapeutics、Crescendo Biologics

目录

第 1 章单株抗体市场概述

  • 调查目的
  • 单株抗体市场定义和范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章：重要考察

第四章单株抗体市场展望

  • 单株抗体市场细分
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章：单株抗体市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 案例研究分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析
  • 近期动态

第六章：单株抗体的市场规模

  • 单株抗体市场规模（以价值计算）
  • 单株抗体市场规模

7. 单株抗体市场类型

  • 市场概况
  • 老鼠
  • 嵌合体
  • 人性化
  • 人类
  • 双重特异性
  • 结合物
  • 多克隆抗体
  • 单复製
  • 其他的

第 8 章：单株抗体市场（按产品）

  • 市场概况
  • 治疗性抗体
  • 诊断抗体
  • 研究抗体
  • 客製化抗体
  • 其他的

第九章单株抗体市场的应用

  • 市场概况
  • 肿瘤学
  • 自体免疫疾病
  • 感染疾病
  • 神经病学
  • 心血管疾病
  • 发炎性疾病
  • 移植
  • 血液学
  • 其他的

第 10 章单株抗体市场（按技术）

  • 市场概况
  • 融合瘤技术
  • 噬菌体展示
  • 基因改造小鼠
  • 细菌展示
  • 酵母展示
  • 单B细胞扩增法
  • 其他的

第 11 章单株抗体市场（依最终用户）

  • 市场概况
  • 医院
  • 研究所
  • 生物製药公司
  • 诊断实验室
  • 合约研究组织
  • 其他的

第 12 章单株抗体市场（依流程）

  • 市场概况
  • in Vivo
  • in Vitro
  • in Silico
  • 其他的

第 13 章：单株抗体市场（依服务）

  • 市场概况
  • 抗体产生
  • 抗体工程
  • 抗体标记
  • 抗体纯化
  • 抗体碎片化
  • 其他的

第 14 章单株抗体市场（依形式）

  • 市场概况
  • 液体
  • 冷冻干燥
  • 其他的

第 15 章单株抗体市场（按部署）

  • 市场概况
  • 内部
  • 外包
  • 其他的

第 16 章：单株抗体市场（依形式）

  • 市场概况
  • 治疗
  • 预防
  • 其他的

第 17 章：按地区分類的单株抗体市场

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十八章竞争格局

  • 概述
  • 市占率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十九章：公司简介

  • BioXcel Therapeutics
  • Aptevo Therapeutics
  • Argenx
  • MacroGenics
  • ImmunoGen
  • Xencor
  • Cellectis
  • MorphoSys
  • Alligator Bioscience
  • Genmab
  • AbCellera
  • Kymab
  • Tiziana Life Sciences
  • Harpoon Therapeutics
  • Crescendo Biologics
简介目录
Product Code: GIS34412

Monoclonal Antibody Market is anticipated to expand from $251.1 billion in 2024 to $837.4 billion by 2034, growing at a CAGR of approximately 12.8%. The Monoclonal Antibody Market encompasses the development and commercialization of antibodies engineered to target specific antigens. These biologics are pivotal in treating various diseases, including cancers, autoimmune disorders, and infectious diseases. The market is driven by advancements in biotechnology, increasing prevalence of chronic diseases, and the growing demand for targeted therapies. Innovations in production techniques and regulatory approvals further accelerate market growth, offering lucrative opportunities for stakeholders.

The Monoclonal Antibody Market is experiencing robust expansion, propelled by advancements in biotechnology and increasing therapeutic applications. The oncology segment is the top-performing sub-segment, driven by the rising prevalence of cancer and the efficacy of monoclonal antibodies in targeting specific cancer cells. The autoimmune diseases sub-segment follows closely, benefiting from the development of novel antibodies that modulate immune responses effectively. Within the therapeutic application segment, the infectious diseases sub-segment is emerging as a promising area, with monoclonal antibodies being explored for treating viral infections. The cardiovascular diseases sub-segment also shows potential, as research progresses in targeting specific pathways involved in heart diseases. The demand for personalized medicine is further enhancing the market's growth trajectory, as monoclonal antibodies allow for tailored treatment approaches. Investments in research and development, along with strategic collaborations, are pivotal in driving innovation and expanding the therapeutic scope of monoclonal antibodies across diverse medical conditions.

Market Segmentation
TypeMurine, Chimeric, Humanized, Human, Bispecific, Conjugated, Polyclonal, Monoclonal
ProductTherapeutic Antibodies, Diagnostic Antibodies, Research Antibodies, Custom Antibodies
ApplicationOncology, Autoimmune Diseases, Infectious Diseases, Neurology, Cardiovascular Diseases, Inflammatory Diseases, Transplantation, Hematology
TechnologyHybridoma Technology, Phage Display, Transgenic Mice, Bacterial Display, Yeast Display, Single B Cell Amplification
End UserHospitals, Research Institutes, Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations
ProcessIn Vivo, In Vitro, In Silico
ServicesAntibody Production, Antibody Engineering, Antibody Labeling, Antibody Purification, Antibody Fragmentation
FormLiquid, Lyophilized
DeploymentIn-house, Outsourced
ModeTherapeutic, Prophylactic

Market Snapshot:

The Monoclonal Antibody Market is characterized by a dynamic distribution of market share, with key players continually vying for dominance through strategic pricing and innovative product launches. The competitive landscape is marked by a robust pipeline of new monoclonal antibody products, driven by technological advancements and growing demand across therapeutic areas. Pricing strategies remain a critical aspect, influenced by manufacturing complexities and regulatory frameworks, which in turn shape market accessibility and adoption rates. The industry is witnessing a surge in biosimilar introductions, reflecting a trend towards cost-effective alternatives and broader market penetration. Competition in the Monoclonal Antibody Market is fierce, with leading companies benchmarking against each other through R&D investments and strategic alliances. Regulatory influences play a pivotal role, particularly in North America and Europe, where stringent approval processes dictate market entry and expansion. The market is further influenced by patent expirations, prompting a shift towards biosimilars and fostering competitive pricing. Analyzing market dynamics reveals a trajectory towards personalized medicine, with monoclonal antibodies at the forefront of this evolution. The landscape is poised for growth, driven by advancements in biotechnology and increasing prevalence of chronic diseases, offering lucrative opportunities for stakeholders.

Geographical Overview:

The monoclonal antibody market is experiencing notable growth across various regions, each offering unique opportunities. North America leads the market, driven by advanced healthcare infrastructure and substantial investments in biotechnology research. The region benefits from a strong presence of pharmaceutical giants and a robust pipeline of monoclonal antibody therapies. Europe follows closely, with significant investments in biopharmaceutical R&D and favorable regulatory frameworks. The region's focus on innovative healthcare solutions and personalized medicine enhances its market potential. In Asia Pacific, the market is expanding rapidly, fueled by rising healthcare expenditures and increasing prevalence of chronic diseases. Emerging economies like China and India are becoming key players due to their large patient populations and improving healthcare systems. Latin America and the Middle East & Africa are emerging markets with growing potential. Latin America's increasing investment in healthcare infrastructure and biotechnology research is driving market growth. Meanwhile, the Middle East & Africa are recognizing the importance of monoclonal antibodies in addressing unmet medical needs, fostering a conducive environment for market expansion.

Key Trends and Drivers:

The monoclonal antibody market is experiencing robust growth, propelled by advancements in biotechnology and genetic engineering. The rising prevalence of chronic diseases, such as cancer and autoimmune disorders, is a significant driver, increasing the demand for targeted therapies. Monoclonal antibodies offer precision treatment options, minimizing adverse effects and improving patient outcomes. The market is further fueled by increased investments in research and development by pharmaceutical companies. Innovations in antibody-drug conjugates and bispecific antibodies are enhancing therapeutic efficacy, creating lucrative opportunities. Regulatory approvals for novel monoclonal antibodies are accelerating, boosting market expansion. Moreover, the COVID-19 pandemic has underscored the importance of monoclonal antibodies in infectious disease management, driving their adoption in new therapeutic areas. The trend towards personalized medicine is also shaping the market, as monoclonal antibodies can be tailored to individual patient needs. With a strong pipeline of products and strategic collaborations, the monoclonal antibody market is poised for sustained growth.

Restraints and Challenges:

The monoclonal antibody market is currently navigating several significant restraints and challenges. One of the primary hurdles is the high cost of production and development. This financial burden limits the accessibility and affordability of these therapies, particularly in emerging markets. Regulatory complexities further exacerbate the situation, with stringent guidelines and lengthy approval processes slowing down the time-to-market for new products. Supply chain disruptions also pose a significant challenge. The reliance on specialized facilities and materials makes the market vulnerable to geopolitical tensions and pandemics, which can lead to shortages and increased costs. Additionally, the rise of biosimilars introduces competitive pressures, compelling companies to innovate continually while managing costs. Lastly, the market faces scientific challenges in targeting complex diseases. Despite technological advances, developing antibodies for certain conditions remains elusive, requiring ongoing research and substantial investment. These factors collectively hinder the market's expansive potential.

Key Players:

BioXcel Therapeutics, Aptevo Therapeutics, Argenx, MacroGenics, ImmunoGen, Xencor, Cellectis, MorphoSys, Alligator Bioscience, Genmab, AbCellera, Kymab, Tiziana Life Sciences, Harpoon Therapeutics, Crescendo Biologics

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Monoclonal Antibody Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Monoclonal Antibody Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Application
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Process
  • 2.9 Key Highlights of the Market, by Services
  • 2.10 Key Highlights of the Market, by Form
  • 2.11 Key Highlights of the Market, by Deployment
  • 2.12 Key Highlights of the Market, by Mode
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Application
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Process
  • 3.8 Market Attractiveness Analysis, by Services
  • 3.9 Market Attractiveness Analysis, by Form
  • 3.10 Market Attractiveness Analysis, by Deployment
  • 3.11 Market Attractiveness Analysis, by Mode
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Monoclonal Antibody Market Outlook

  • 4.1 Monoclonal Antibody Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Monoclonal Antibody Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Monoclonal Antibody Market Size

  • 6.1 Monoclonal Antibody Market Size, by Value
  • 6.2 Monoclonal Antibody Market Size, by Volume

7: Monoclonal Antibody Market, by Type

  • 7.1 Market Overview
  • 7.2 Murine
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Chimeric
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Humanized
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Human
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Bispecific
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Conjugated
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Polyclonal
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Monoclonal
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Others
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region

8: Monoclonal Antibody Market, by Product

  • 8.1 Market Overview
  • 8.2 Therapeutic Antibodies
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Diagnostic Antibodies
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Research Antibodies
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Custom Antibodies
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Monoclonal Antibody Market, by Application

  • 9.1 Market Overview
  • 9.2 Oncology
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Autoimmune Diseases
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Infectious Diseases
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Neurology
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Cardiovascular Diseases
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Inflammatory Diseases
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Transplantation
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region
  • 9.9 Hematology
    • 9.9.1 Key Market Trends & Opportunity Analysis
    • 9.9.2 Market Size and Forecast, by Region
  • 9.10 Others
    • 9.10.1 Key Market Trends & Opportunity Analysis
    • 9.10.2 Market Size and Forecast, by Region

10: Monoclonal Antibody Market, by Technology

  • 10.1 Market Overview
  • 10.2 Hybridoma Technology
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Phage Display
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Transgenic Mice
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Bacterial Display
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Yeast Display
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Single B Cell Amplification
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Others
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region

11: Monoclonal Antibody Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Research Institutes
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Biopharmaceutical Companies
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Diagnostic Laboratories
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Contract Research Organizations
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Others
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region

12: Monoclonal Antibody Market, by Process

  • 12.1 Market Overview
  • 12.2 In Vivo
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 In Vitro
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 In Silico
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Monoclonal Antibody Market, by Services

  • 13.1 Market Overview
  • 13.2 Antibody Production
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Antibody Engineering
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Antibody Labeling
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Antibody Purification
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Antibody Fragmentation
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Others
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region

14: Monoclonal Antibody Market, by Form

  • 14.1 Market Overview
  • 14.2 Liquid
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Lyophilized
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Monoclonal Antibody Market, by Deployment

  • 15.1 Market Overview
  • 15.2 In-house
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Outsourced
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Monoclonal Antibody Market, by Mode

  • 16.1 Market Overview
  • 16.2 Therapeutic
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Prophylactic
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Others
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region

17: Monoclonal Antibody Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Application
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by End User
    • 17.2.7 North America Market Size and Forecast, by Process
    • 17.2.8 North America Market Size and Forecast, by Services
    • 17.2.9 North America Market Size and Forecast, by Form
    • 17.2.10 North America Market Size and Forecast, by Deployment
    • 17.2.11 North America Market Size and Forecast, by Mode
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Application
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by End User
      • 17.2.9.6 United States Market Size and Forecast, by Process
      • 17.2.9.7 United States Market Size and Forecast, by Services
      • 17.2.9.8 United States Market Size and Forecast, by Form
      • 17.2.9.9 United States Market Size and Forecast, by Deployment
      • 17.2.9.10 United States Market Size and Forecast, by Mode
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Application
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by End User
      • 17.2.10.6 Canada Market Size and Forecast, by Process
      • 17.2.10.7 Canada Market Size and Forecast, by Services
      • 17.2.10.8 Canada Market Size and Forecast, by Form
      • 17.2.10.9 Canada Market Size and Forecast, by Deployment
      • 17.2.10.10 Canada Market Size and Forecast, by Mode
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Application
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by End User
    • 17.3.7 Europe Market Size and Forecast, by Process
    • 17.3.8 Europe Market Size and Forecast, by Services
    • 17.3.9 Europe Market Size and Forecast, by Form
    • 17.3.10 Europe Market Size and Forecast, by Deployment
    • 17.3.11 Europe Market Size and Forecast, by Mode
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Form
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Application
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by End User
      • 17.3.10.6 Germany Market Size and Forecast, by Process
      • 17.3.10.7 Germany Market Size and Forecast, by Services
      • 17.3.10.8 Germany Market Size and Forecast, by Form
      • 17.3.10.9 Germany Market Size and Forecast, by Deployment
      • 17.3.10.10 Germany Market Size and Forecast, by Mode
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Application
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by End User
      • 17.3.11.6 France Market Size and Forecast, by Process
      • 17.3.11.7 France Market Size and Forecast, by Services
      • 17.3.11.8 France Market Size and Forecast, by Form
      • 17.3.11.9 France Market Size and Forecast, by Deployment
      • 17.3.11.10 France Market Size and Forecast, by Mode
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Application
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by End User
      • 17.3.12.6 Spain Market Size and Forecast, by Process
      • 17.3.12.7 Spain Market Size and Forecast, by Services
      • 17.3.12.8 Spain Market Size and Forecast, by Form
      • 17.3.12.9 Spain Market Size and Forecast, by Deployment
      • 17.3.12.10 Spain Market Size and Forecast, by Mode
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Application
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by End User
      • 17.3.13.6 Italy Market Size and Forecast, by Process
      • 17.3.13.7 Italy Market Size and Forecast, by Services
      • 17.3.13.8 Italy Market Size and Forecast, by Form
      • 17.3.13.9 Italy Market Size and Forecast, by Deployment
      • 17.3.13.10 Italy Market Size and Forecast, by Mode
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Application
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by End User
      • 17.3.14.6 Netherlands Market Size and Forecast, by Process
      • 17.3.14.7 Netherlands Market Size and Forecast, by Services
      • 17.3.14.8 Netherlands Market Size and Forecast, by Form
      • 17.3.14.9 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.10 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Application
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by End User
      • 17.3.15.6 Sweden Market Size and Forecast, by Process
      • 17.3.15.7 Sweden Market Size and Forecast, by Services
      • 17.3.15.8 Sweden Market Size and Forecast, by Form
      • 17.3.15.9 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.10 Sweden Market Size and Forecast, by Mode
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Application
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by End User
      • 17.3.16.6 Switzerland Market Size and Forecast, by Process
      • 17.3.16.7 Switzerland Market Size and Forecast, by Services
      • 17.3.16.8 Switzerland Market Size and Forecast, by Form
      • 17.3.16.9 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.10 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Application
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by End User
      • 17.3.17.6 Denmark Market Size and Forecast, by Process
      • 17.3.17.7 Denmark Market Size and Forecast, by Services
      • 17.3.17.8 Denmark Market Size and Forecast, by Form
      • 17.3.17.9 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.10 Denmark Market Size and Forecast, by Mode
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Application
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by End User
      • 17.3.18.6 Finland Market Size and Forecast, by Process
      • 17.3.18.7 Finland Market Size and Forecast, by Services
      • 17.3.18.8 Finland Market Size and Forecast, by Form
      • 17.3.18.9 Finland Market Size and Forecast, by Deployment
      • 17.3.18.10 Finland Market Size and Forecast, by Mode
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Application
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by End User
      • 17.3.19.6 Russia Market Size and Forecast, by Process
      • 17.3.19.7 Russia Market Size and Forecast, by Services
      • 17.3.19.8 Russia Market Size and Forecast, by Form
      • 17.3.19.9 Russia Market Size and Forecast, by Deployment
      • 17.3.19.10 Russia Market Size and Forecast, by Mode
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Form
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Form
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Application
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by End User
      • 17.4.9.6 China Market Size and Forecast, by Process
      • 17.4.9.7 China Market Size and Forecast, by Services
      • 17.4.9.8 China Market Size and Forecast, by Form
      • 17.4.9.9 China Market Size and Forecast, by Deployment
      • 17.4.9.10 China Market Size and Forecast, by Mode
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Application
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by End User
      • 17.4.10.6 India Market Size and Forecast, by Process
      • 17.4.10.7 India Market Size and Forecast, by Services
      • 17.4.10.8 India Market Size and Forecast, by Form
      • 17.4.10.9 India Market Size and Forecast, by Deployment
      • 17.4.10.10 India Market Size and Forecast, by Mode
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Application
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by End User
      • 17.4.11.6 Japan Market Size and Forecast, by Process
      • 17.4.11.7 Japan Market Size and Forecast, by Services
      • 17.4.11.8 Japan Market Size and Forecast, by Form
      • 17.4.11.9 Japan Market Size and Forecast, by Deployment
      • 17.4.11.10 Japan Market Size and Forecast, by Mode
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Application
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by End User
      • 17.4.12.6 South Korea Market Size and Forecast, by Process
      • 17.4.12.7 South Korea Market Size and Forecast, by Services
      • 17.4.12.8 South Korea Market Size and Forecast, by Form
      • 17.4.12.9 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.10 South Korea Market Size and Forecast, by Mode
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Application
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by End User
      • 17.4.13.6 Australia Market Size and Forecast, by Process
      • 17.4.13.7 Australia Market Size and Forecast, by Services
      • 17.4.13.8 Australia Market Size and Forecast, by Form
      • 17.4.13.9 Australia Market Size and Forecast, by Deployment
      • 17.4.13.10 Australia Market Size and Forecast, by Mode
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Application
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by End User
      • 17.4.14.6 Singapore Market Size and Forecast, by Process
      • 17.4.14.7 Singapore Market Size and Forecast, by Services
      • 17.4.14.8 Singapore Market Size and Forecast, by Form
      • 17.4.14.9 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.10 Singapore Market Size and Forecast, by Mode
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Application
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by End User
      • 17.4.15.6 Indonesia Market Size and Forecast, by Process
      • 17.4.15.7 Indonesia Market Size and Forecast, by Services
      • 17.4.15.8 Indonesia Market Size and Forecast, by Form
      • 17.4.15.9 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.10 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Application
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by End User
      • 17.4.16.6 Taiwan Market Size and Forecast, by Process
      • 17.4.16.7 Taiwan Market Size and Forecast, by Services
      • 17.4.16.8 Taiwan Market Size and Forecast, by Form
      • 17.4.16.9 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.10 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Application
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by End User
      • 17.4.17.6 Malaysia Market Size and Forecast, by Process
      • 17.4.17.7 Malaysia Market Size and Forecast, by Services
      • 17.4.17.8 Malaysia Market Size and Forecast, by Form
      • 17.4.17.9 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.10 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Application
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by End User
    • 17.5.7 Latin America Market Size and Forecast, by Process
    • 17.5.8 Latin America Market Size and Forecast, by Services
    • 17.5.9 Latin America Market Size and Forecast, by Form
    • 17.5.10 Latin America Market Size and Forecast, by Deployment
    • 17.5.11 Latin America Market Size and Forecast, by Mode
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Application
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by End User
      • 17.5.9.6 Brazil Market Size and Forecast, by Process
      • 17.5.9.7 Brazil Market Size and Forecast, by Services
      • 17.5.9.8 Brazil Market Size and Forecast, by Form
      • 17.5.9.9 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.10 Brazil Market Size and Forecast, by Mode
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Application
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by End User
      • 17.5.10.6 Mexico Market Size and Forecast, by Process
      • 17.5.10.7 Mexico Market Size and Forecast, by Services
      • 17.5.10.8 Mexico Market Size and Forecast, by Form
      • 17.5.10.9 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.10 Mexico Market Size and Forecast, by Mode
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Application
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by End User
      • 17.5.11.6 Argentina Market Size and Forecast, by Process
      • 17.5.11.7 Argentina Market Size and Forecast, by Services
      • 17.5.11.8 Argentina Market Size and Forecast, by Form
      • 17.5.11.9 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.10 Argentina Market Size and Forecast, by Mode
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Form
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Form
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Form
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Application
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by End User
      • 17.6.10.6 UAE Market Size and Forecast, by Process
      • 17.6.10.7 UAE Market Size and Forecast, by Services
      • 17.6.10.8 UAE Market Size and Forecast, by Form
      • 17.6.10.9 UAE Market Size and Forecast, by Deployment
      • 17.6.10.10 UAE Market Size and Forecast, by Mode
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Application
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by End User
      • 17.6.11.6 South Africa Market Size and Forecast, by Process
      • 17.6.11.7 South Africa Market Size and Forecast, by Services
      • 17.6.11.8 South Africa Market Size and Forecast, by Form
      • 17.6.11.9 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.10 South Africa Market Size and Forecast, by Mode
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Form
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 BioXcel Therapeutics
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Aptevo Therapeutics
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Argenx
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 MacroGenics
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 ImmunoGen
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Xencor
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Cellectis
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 MorphoSys
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Alligator Bioscience
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Genmab
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 AbCellera
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Kymab
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Tiziana Life Sciences
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Harpoon Therapeutics
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Crescendo Biologics
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis